Krzysztof Czyżewski Selected Research

Krzysztof Czyżewski Research Topics

7	Infections 12/2023 - 10/2019
4	Virus Diseases (Viral Diseases) 09/2022 - 09/2019
3	Neoplasms (Cancer) 03/2024 - 01/2012
3	Bacterial Infections (Bacterial Infection) 12/2023 - 10/2019
3	Mycoses (Diseases, Fungus) 01/2020 - 09/2019
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 01/2020
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2021 - 01/2012
1	COVID-19 03/2024
1	Hodgkin Disease (Hodgkin's Disease) 08/2023
1	Disease Progression 01/2022
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022
1	Epstein-Barr Virus Infections 01/2022
1	Hydroa Vacciniforme 01/2022
1	Common Variable Immunodeficiency 01/2022
1	Hemorrhagic Cystitis 05/2021
1	Herpes Zoster 12/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2019
1	Fever (Fevers) 01/2019
1	Vasculitis (Vasculitides) 01/2019
1	Nijmegen Breakage Syndrome 01/2019
1	Mucositis 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2012

1	Chimeric Antigen ReceptorsIBA 03/2024
1	cilgavimabIBA 03/2024
1	tixagevimabIBA 03/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2021
1	Busulfan (Busulfex)FDA Link 05/2021
1	Melphalan (Alkeran)FDA LinkGeneric 05/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	SteroidsIBA 12/2020
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2012
1	Bortezomib (Velcade)FDA Link 01/2012
1	Tyrosine Kinase InhibitorsIBA 01/2012

7	Therapeutics 03/2024 - 12/2020
5	Hematopoietic Stem Cell Transplantation 03/2024 - 01/2019
5	Cell Transplantation 01/2022 - 09/2019
4	Drug Therapy (Chemotherapy) 12/2023 - 10/2019
3	Transplantation 01/2022 - 01/2019
1	Antibiotic Prophylaxis 12/2023
1	Duration of Therapy 11/2019